Trailblazing perspectives on targeting breast cancer stem cells-Reference-Cited by-同舟云学术

Trailblazing perspectives on targeting breast cancer stem cells

Published:2021-07 Issue: Volume:223 Page:107800
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Li Juntao,Qi Dan,Hsieh Tze-Chen,Huang Jason H.,Wu Joseph M.,Wu Erxi

Funder

Corbett Estate Fund for Cancer Research, USA

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference259 articles.

1. Recent advances in targeting of breast cancer stem cells based on biological concepts and drug delivery system modification;Aaliyari-Serej;Adv Pharm Bull,2020

2. Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen;Adams;Cancer Research,2000

3. Cancer stem cells: the promise and the potential;Ajani;Seminars in Oncology,2015

4. A Stemness and EMT Based Gene Expression Signature Identifies Phenotypic Plasticity and is A Predictive but Not Prognostic Biomarker for Breast Cancer;Akbar;Journal of Cancer,2020

5. Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors;Akbay;Cancer Discovery,2013

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials;Molecular Cancer;2023-10-02

2. Study on the Diagnosis of Breast Cancer by Fluorescence Spectrometry Based on Machine Learning;SPECTROSC SPECT ANAL;2023

3. Emerging role of interactions between tumor angiogenesis and cancer stem cells;Journal of Controlled Release;2023-08

4. Targeting tumor endothelial cells with methyltransferase inhibitors: Mechanisms of action and the potential of combination therapy;Pharmacology & Therapeutics;2023-07

5. A Concise Review of Prodigious Salinomycin and Its Derivatives Effective in Treatment of Breast Cancer: (2012–2022);International Journal of Translational Medicine;2023-05-05